Answers are grounded in this paper and cite their sources.
Evaluates dorzolamide hydrochloride delivery in glaucoma treatment, suggesting improved absorption method.
Introduction/Objective: Increased intraocular pressure in the normal eye causes damage to the optic nerves, resulting in vision loss in patients with glaucoma. Glaucoma is treat-ed with topical carbonic anhydrase inhibitors (CAIs), beta blockers, prostaglandin analogs, and alpha-agonists. The topical application of CAIs enters the ciliary body epithelium and passes through the cornea, thereby lowering the generation of bicarbonate ions. Carbon nanotubes (CNTs) are widely used to efficiently and safely transport molecules across nuclear or cytoplas-mic membranes. SLNs are useful for delivering drugs into the eyes by increasing corneal absorp-tion, boosting ocular bioavailability, extending ocular retention time, and providing sustained drug release. Therefore, this study aimed to formulate and evaluate dorzolamide hydrochloride-loaded solid lipid nanoparticles (SLNs) embedded in carbon nanotubes (CNTs) derived from different sources for the treatment of glaucoma. Methods: A comparative evaluation of the CNT-SLN formulations prepared from these different sources was conducted to assess their potential for enhancing corneal drug absorption. Response surface methodology was employed to design and optimize the experiment using a 23-factorial design. The goal of the study was to develop a stable, biodegradable nanocarrier with improved stability, sustained release, and higher drug entrapment by optimizing formulation variables. The optimized SLNs for dorzolamide hydrochloride were prepared using Design-Expert software with a 23 Factorial Design, while CNTs were prepared from various sources, including coconut, carrot, ghee, and camphor. In this study, the CNT-SLN complex was prepared and evaluated using various parameters, and it was confirmed to be successfully synthesized. FESEM revealed the morphology of SLN and CNT-SLN. Results: SLNs were well coated onto CNT. The biphasic release was observed in the in vitro release of CNT-SLN batches, with an initial burst, followed by sustained release over time, consistent with the Korsmeyer-Peppas release kinetics model, indicating Fickian diffusion. Discussion: The formulation of dorzolamide hydrochloride-loaded solid lipid nanoparticles (SLNs) embedded in carbon nanotubes (CNTs) derived from coconut, carrot, ghee, and camphor kajal formulations was used for the treatment of glaucoma. A 23-factorial design was used for experimental design and optimization via response surface methodology. The results for various parameters, such as drug entrapment, biphasic release profile, stability, etc., for all formulations were found to be satisfactory. Hence, the prepared formulation of dorzolamide hydrochloride was found to be well accepted after an in vitro study. Conclusion: In this study, a CNT-SLN formulation of dorzolamide hydrochloride was prepared from different sources and evaluated for various parameters; the results were satisfactory. Hence, the optimized formulation, with further preclinical studies, can be used for the treatment of glaucoma.
No takes yet. Share an insight, caveat, or question.
Sakpal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: